Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia

Tropical Medicine and International Health

Volumn 9, Issue 1, 2004, Pages 62-67

  Depoortere, Evelyn ^a   Guthmann, Jean Paul ^a   Sipilanyambe, Naawa ^b   Nkandu, Esther ^c   Fermon, Florence ^d   Balkan, Suna ^d   Legros, Dominique ^a  

^a EPICENTRE   (France)

^b National Malaria Control Centre   (Zambia)

^c UNIVERSITY OF ZAMBIA   (Zambia)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

Adherence; Artemisinin based combination therapy; Artesunate; Malaria; Sulphadoxine pyrimethamine; Zambia

Indexed keywords

ARTESUNATE; FANSIDAR;

DISEASE TREATMENT; MALARIA; REFUGEE;

AGE DISTRIBUTION; ARTICLE; CAREGIVER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NEWBORN; PATIENT CODING; PRESCHOOL CHILD; PRESCRIPTION; PROFESSIONAL PRACTICE; QUESTIONNAIRE; REFUGEE; ZAMBIA;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FAMILY; FEMALE; HEALTH EDUCATION; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PATIENT COMPLIANCE; PYRIMETHAMINE; QUESTIONNAIRES; REFUGEES; SESQUITERPENES; SULFADOXINE; TREATMENT REFUSAL; ZAMBIA;

AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA; ZAMBIA;

ARTESUNATE; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0842287132     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01157.x     Document Type: Article

References (28)

1. Agyepong IA, Ansah E, Gyapong M, Adjei S, Barnish G & Evans D (2002) Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Social Science and Medicine 55, 2215-2226.
2. Ansah EK, Gyapong JO, Agyepong IA & Evans DB (2001) Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Tropical Medicine and International Health 6, 496-504.
3. Baker L & Barnes K (2001) New antimalarial treatment for KwaZulu-Natal. South African Medical Journal 91, 358-359.
4. Berkow R (ed.) (1992) Compliance with drug treatment. In: The Merck Manual of Diagnosis and Therapy, 16th edn. Merck Research Laboratories, Philadelphia, pp. 2646-2647.
5. Bijl HM, Kager J, Koetsier DW & Van der Werf TS (2000) Chloroquine- and sulfadoxine-pyrimethamine-resistant falciparum malaria in vivo - a pilot study in rural Zambia. Tropical Medicine and International Health 5, 692-695.
6. Bloland PB (2001) Drug Resistance in Malaria. World Health Organization, Geneva.
7. Bloland PB, Ettling M & Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization 78, 1378-1388.
8. Deming MS, Gayibor A, Murphy K, Jones TS & Karsa T (1989) Home treatment of febrile children with antimalarial drugs in Togo. Bulletin of the World Health Organization 67, 695-700.
9. Ejezie GC, Ezedinachi ENU, Usanga EA, Gemade EII, Ikpatt NW & Alaribe AA (1990) Malaria and its treatment in rural villages of Aboh Mbaise, Imo State, Nigeria. Acta Tropica 48, 17-24.
10. Gomes M, Wayling S & Pang L (1998) Interventions to improve the use of antimalarials in South-East Asia: an overview. Bulletin of the World Health Organization 76 (Suppl. 1), 9-19.
11. Marsh K (1998) Malaria disaster in Africa. Lancet 352, 924.
12. Na-Bangchang K, Congpuong K, Sirichaisinthop J, Suprakorb K & Karbwang J (1997) Compliance with a 2 day course of artemether-mefloquine in an area of high multi-drug resistant Plasmodium falciparum malaria. British Journal of Clinical Pharmacology 43, 639-642.
13. NMCC (1999) Drug Sensitivity Study Summary Report. October 1999-February 2000. National Malaria Control Centre, Lusaka, Zambia.
14. Nshakira N, Kristensen M, Ssali F & Reynolds Whyte S (2002) Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Tropical Medicine and International Health 7, 309-316.
15. Okonkwo PO, Akpala CO, Okafor HU, Mbah AU amp; Nwaiwu O (2001) Compliance with correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 320-324.
16. Price RN & Nosten F (2001) Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resistance Updates 4, 1-10.
17. Roll Back Malaria (2003) Global Anti-Malaria Drug Policies Database: AFRO. Unpublished document. Available at: http://mosquito.who.int/cgi-bin/rbm/ dhome_rbm.jsp (last accessed: 8 September 2003).
18. Shwe T, Lwin M & Aung S (1998) Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar. Bulletin of the World Health Organization 76 (Suppl. 1), 35-41.
19. Slutsker L, Chitsulo L, Macheso A & Steketee RW (1994) Treatment of malaria fever episodes among children in Malawi: results of a KAP survey. Tropical Medicine and Parasitology 45, 61-64.
20. Trape JF (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64 (Suppl.), 12-17.
21. UNHCR (2002) Maheba Census, February 2002. United Nations High Commissioner for Refugees, Zambia.
22. Vundule C & Mharakurwa S (1996) Knowledge, practices, and perceptions about malaria in rural communities of Zimbabwe: relevance to malaria protocol. Bulletin of the World Health Organization 74, 55-60.
23. White NJ (1999) Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41, 301-308.
24. White NJ & Olliaro PL (1996) Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today 12, 399-401.
25. White NJ, Nosten F, Looareesuwan S et al. (1999) Averting a malaria disaster. Lancet 353, 1965-1967.
26. WHO (2001) The World Health Report 2001. World Health Organisation, Geneva.
27. Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB & Adjei S (2001) Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bulletin of the World Health Organization 79, 394-399.
28. Yeneneh H, Gyorkos TW, Joseph L, Pickering J & Tedla S (1993) Antimalarial drug utilization by women in Ethiopia: a knowledge-attitudes- practice study. Bulletin of the World Health Organization 71, 763-772.